Seeing cancer biology at a finer scale

The Review examines how quantum dots, nanoscale fluorescent probes, may complement established imaging in recurrent prostate cancer. Coupling them to ligands that recognize prostate-specific membrane antigen (PSMA) can support molecularly targeted optical measurements.

The emphasis is on bridging whole-body imaging and cellular-scale analysis. Brightness, photostability, and tunable emission offer opportunities for multiplexed imaging, while heterogeneous PSMA expression remains an important biological consideration.

Promise—and the limits of translation

The authors compare material and targeting strategies alongside toxicity, biodistribution, and clearance. Quantum dots are positioned as complementary research and translational tools, not replacements for PSMA PET/CT. Preclinical studies, tissue analysis, and intraoperative imaging are potential contexts; clinical application still requires substantial safety and validation work.